Daehan Pharmaceutical대한약품
023910 · KOSDAQ · ₩023910 · 대한약품
- Market cap
- ₩149B
- Enterprise value
- ₩90B
- P/E
- 5.3×
- P/B
- 0.5×
- Dividend yield
- 4.0%
- ROE
- 9.2%
- Net margin
- 13.0%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−21.3% from the high
₩24,000Today: ₩24,900 – ₩25,350₩31,650
Returns
- 1W−2.5%
- 1M−4.0%
- 3M−2.4%
- 6M−14.1%
- YTD−14.9%
- 1Y−15.0%
- Volume today
- 8,444
- 1.5× the 20-day average
- Traded today
- ₩212M
- Listed shares
- 6,000,000
- EPS (12 months)
- ₩4,699
- Earnings yield 18.9%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Normal- BuzzNormalBuzz 49 of 100 (50 is a normal day for this stock).
- MomentumWeak-5.3% over the last month; the price is below its 20-day average.
- News impactLow2 news items and filings in two weeks; 0 rated high impact, 0 medium.
Signals describe activity, not recommendations. Not financial advice.
Daehan Pharmaceutical stock overview
Daehan Pharmaceutical (대한약품, KRX: 023910) is listed on KOSDAQ, in the Biotech & Pharma sector. Daehan Pharm produces and sells basic pharmaceuticals, mainly intravenous fluids, ampoules and vials, and parenteral nutrition infusions used by hospitals and clinics, and also sells over-the-counter products such as lens cleaning solution through pharmacies. Its shares closed at ₩24,900 on Oct 28, 2026, down 1.19% on the day, giving it a market value of ₩149B.
Key facts
- Market cap
- ₩149B
- Sector
- Biotech & Pharma
- Latest price change
- −1.19%
- As of
- Oct 28, 2026
- Main business
- Daehan Pharm produces and sells basic pharmaceuticals, mainly intravenous fluids, ampoules and vials, and parenteral nutrition infusions used by hospitals and clinics, and also sells over-the-counter products such as lens cleaning solution through pharmacies.
Quick answers about Daehan Pharmaceutical
- What does Daehan Pharmaceutical do?
- Daehan Pharm produces and sells basic pharmaceuticals, mainly intravenous fluids, ampoules and vials, and parenteral nutrition infusions used by hospitals and clinics, and also sells over-the-counter products such as lens cleaning solution through pharmacies. The company also exports to Southeast Asian countries and operates its manufacturing plant in Banwol, Ansan, Korea, with customers in hospitals, clinics and pharmacies accounting for most of its sales.
- What is the market cap of Daehan Pharmaceutical?
- The market capitalisation of Daehan Pharmaceutical was ₩149B at the close on Oct 28, 2026.
- Who are the largest shareholders of Daehan Pharmaceutical?
- According to the latest official filings, the largest reported holders are Lee Yun-woo (25.01%, as of Oct 23, 2026); Fidelity Management & Research Company LLC (8.14%, as of Aug 6, 2026); Lee Seung-young (6.37%, as of Mar 13, 2025).
- When is the next earnings report from Daehan Pharmaceutical?
- Korean companies rarely announce results dates in advance. Based on when Daehan Pharmaceutical filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
- Does the National Pension Service own Daehan Pharmaceutical?
- Yes. The National Pension Service held 1.35% of Daehan Pharmaceutical shares as of Dec 31, 2025.
Company profile
Daehan Pharm produces and sells basic pharmaceuticals, mainly intravenous fluids, ampoules and vials, and parenteral nutrition infusions used by hospitals and clinics, and also sells over-the-counter products such as lens cleaning solution through pharmacies. The company also exports to Southeast Asian countries and operates its manufacturing plant in Banwol, Ansan, Korea, with customers in hospitals, clinics and pharmacies accounting for most of its sales.
Written by AI from the company's latest annual report.
- Korean name
- 대한약품
- Sector
- Biotech & Pharma
- Themes
- Pharmaceuticals
- CEO
- 이승영
- Founded
- May 1963
- Listed
- Nov 1994
- Listed shares
- 6,000,000
- Fiscal year ends
- Month 12
- Website
- www.daihan.com
Similar companies
- Samsung Biologics207940 · ₩64T₩1,372,000−0.15%
- Celltrion068270 · ₩44T₩189,800+0.64%
- Alteogen196170 · ₩16T₩223,000+2.06%
- SK biopharmaceuticals326030 · ₩5.9T₩75,200+0.40%
- Yuhan000100 · ₩5.7T₩77,300−3.38%
- HLB028300 · ₩5.4T₩40,650+1.88%
- Hanmi Pharm128940 · ₩4.7T₩369,500+5.42%
- SAM Chun Dang Pharm000250 · ₩4.5T₩190,000+1.28%
Recent filings
See all- Insider shareholding reportOct 23, 2026
- Insider shareholding reportOct 20, 2026
- Insider shareholding reportOct 8, 2026
- Insider shareholding reportSep 30, 2026
- Insider shareholding reportAug 31, 2026
Titles in Korean until English translations are added.
Also known as: Daehan Pharmaceutical / 대한약품 / 023910 / KRX:023910
Source: KRX statistical information